November 20th 2008, 4 pm, large lecture hall at MedILS
Natural substances may interact with numerous target proteins in human cells. For the flavonoid quercetin a method has been developed which allows the identification of unknown target proteins. The target proteins that have been of particular interest to us include the cytoskeletal proteins actin and tubulin and their associated motor proteins. New inhibitors for these proteins have been identified and the effect of the inhibitors studied in various cellular test systems. Possible medical applications will be discussed.
Interaction of natural substances with cellular target proteins (prof. dr. Herwig Gutzeit, TU Dresden, Germany)
Genomic principles for feedback regulation of metabolism
Nick Luscombe, PhD
European Bioinformatics Institute
Wellcome Trust Genome Campus
Cambridge, UK
MedILS, konferencijska sala, 17. lipanj 2008, 16:00 h
Dr. Ikeda’s lecture on ubiquitin and ubiquitin like molecules in the regulation of signaling
Ubiquitin is a small molecule, so-named for its extraordinary wide distribution from yeast to man. The covalent ubiquitylation of proteins is a widespread regulatory post-translational modification, as like protein phosphorylation. Early interest in ubiquitylation centered on the role of polyubiquitin chains in targeting proteins for degradation. However, ubiquitin is now revealed to be involved in many biological functions.
MedILS, September 17th 2007
Dr. Dimitri Krainc, MedILS and Harvard University
Molecular Biology of Neurodegenerative Diseases
MedILS, August 14th 2007
Prof. dr. Miroslav Radman
Reassembly of Shattered Chromosomes in the bacterium Deinococcues Radiodurans
MedILS, July 17th 2007
Dr. Bojan Žagrović, MedILS
Studying the Extremes of Biomolecular Dynamics using Computational Tools
MedILS, July 12th 2007
Prof. dr. Tom Šmuc, IRB, Zagreb
Applications of Supervised Learning in Biology
MedILS, July 12th 2007
Prof. dr. Andrew Rutenberg, Delhousie University, Canada
Statistical Mechanics of the Timing of Phage Lysis
MedILS, July 10th 2007
Dr. Iva Tolić Norrelykke, Max Planck Institute, Dresden, Germany
Biophysical Studies of Cell Architecture
MedILS, June 29th 2007